Concepedia
Statistics
Publications
38
Citations
3.8K
H-Index
27
Active since
2006
Affiliations
University of Exeter(Current)
Royal Devon & Exeter NHS Foundation Trust
Alexion Pharmaceuticals (United States)
Leeds Teaching Hospitals NHS Trust
NIHR Exeter Clinical Research Facility
Anita Hill is an author at University of Exeter specializing in medicine, endocrinology, and hematology.
Publications per year
2006–2023
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Richard Kelly, Anita Hill, Louise Arnold et al. · Blood · 2011 · 516 citations · Full text
Medicine, Hematology, Pharmacotherapy +5
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
Jong Wook Lee, Flore Sicre de Fontbrune, Lily Wong Lee Lee et al. · Blood · 2018 · 400 citations · Full text
Life Sciences, Immunology, Pharmacology +11
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor–experienced adult patients with PNH: the 302 study
Austin Kulasekararaj, Anita Hill, Scott T. Rottinghaus et al. · Blood · 2018 · 378 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +5
A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults
Richard A. Oram, Kashyap Patel, Anita Hill et al. · Diabetes Care · 2015 · 369 citations · Full text
Life Sciences, Endocrinology, Genetics +17
Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization
Anita Hill, Russell P. Rother, L Arnold et al. · Haematologica · 2010 · 191 citations · Full text
Medicine, Clinical Sciences, Hematology +15
1–5 of 38